BBI503

· Sumitomo Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BBI503, covering 2021-09-09 to 2023-11-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer [Phase 2]